Angioedema - 90 Studies Found
| Completed |
: Pharmacogenetics of Ace Inhibitor-Associated Angioedema :
: 2011-08-08 :
|
| Completed |
: Significance of an Elimination and Provocation Diet in Patients With Chronic Urticaria :
: 2006-10-06 :
|
| Completed |
: OPTIMA: Efficacy of Optimized Re-treatment and Step-up Therapy With Omalizumab in Chronic Spontaneous Urticaria (CSU) Patients : Chonic Spontaneous Urticaria : 2014-06-10 :
|
| Completed |
: Efficacy and Safety Study of DX-2930 to Prevent Acute Angioedema Attacks in Patients With Type I and Type II HAE : Hereditary Angioedema : 2015-10-23 :
|
| Completed |
: CSL312_3003 Safety and Pharmacokinetic Study in Subjects 2 to 11 Years of Age With Hereditary Angioedema : Hereditary Angioedema (HAE) : 2025-08-07 : Fully human immunoglobulin G subclass 4/lambda recombinant inhibitor monoclonal antibody administered subcutaneously (SC) |
| Completed |
: A Study of STAR-0215 in Participants With Hereditary Angioedema : Hereditary Angioedema : 2025-08-07 : STAR-0215 will be administered as a subcutaneous bolus injection. |
| COMPLETED |
: A Study in Adults With Hereditary Angioedema (HAE) Who Currently Receive Icatibant at Home : Hereditary Angioedema (HAE) : 2025-08-07 : No Intervention will be administered in this study. |
| COMPLETED |
: A Study of Lanadelumab in Persons With Hereditary Angioedema (HAE) Type I or II : Hereditary Angioedema (HAE) : 2025-08-07 |
| COMPLETED |
: A Study of STAR-0215 in Participants With Hereditary Angioedema : Hereditary Angioedema : 2025-08-07 : STAR-0215 will be administered as a subcutaneous bolus injection. |
| COMPLETED |
: Dose-ranging Study of Oral PHA-022121 for Prophylaxis Against Angioedema Attacks in Patients With Hereditary Angioedema Type I or Type II : Hereditary Angioedema : 2025-08-07 : Deucrictibant softgel capsules for oral use (PHVS416) |